Campto - Irinotecan Injection

Campto - Irinotecan Injection Specification

Salt Composition
Irinotecan Hydrochloride Trihydrate

Dosage Form
Injection

Indication
Used for the treatment of metastatic carcinoma of the colon or rectum

Feature
Ready to use, sterile preparation

Ingredients
Irinotecan Hydrochloride as active ingredient, Water for Injection as excipient

Application

Physical Color/Texture
Clear, colorless to pale yellow solution

Fermentation Smell
Odorless

Storage Instructions
Store between 2C to 8C, protect from light

Shelf Life
24 months

About Campto - Irinotecan Injection

Campto - Irinotecan Injection:-

CAMPTO is indicated for the treatment of patients with advanced colorectal cancer:

In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for advanced disease,
As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen.

CAMPTO in combination with is indicated for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, KRAS wild-type metastatic colorectal cancer, who had not received prior treatment for metastatic disease or after failure of irinotecan-including cytotoxic therapy (please see 5.1).

CAMPTO in combination with 5-fluorouracil, folinic acid and bevacizumab is indicated for first-line treatment of patients with metastatic carcinoma of the colon or rectum.

Campto in combination with capecitabine with or without bevacizumab is indicated for first-line treatment of patients with metastatic colorectal carcinoma.

Uses and Benefits

Campto is specifically utilized in the treatment of metastatic colorectal cancer. As an anticancer chemotherapy agent, it works by inhibiting the replication of cancerous cells, helping to control the progression of the disease. Its ready-to-use, sterile formulation ensures rapid preparation and administration by healthcare professionals.

Administration Guidelines

This injection is intended exclusively for intravenous infusion after proper dilution with standard infusion solutions. The process should be conducted by suitably trained healthcare personnel in a clinical environment, following established protocols for safe chemotherapy administration.

Storage and Handling

To maintain the stability and sterility of Campto, store the glass vial refrigerated at 2C to 8C and protect it from light. Do not freeze. Follow the expiration and shelf-life instructions, and always inspect the solution for particulates or discoloration before use.

FAQs of Campto - Irinotecan Injection:

Q: How should Campto - Irinotecan Injection be prepared and administered?

A: Campto must be diluted with a compatible standard infusion solution before administration. It is administered intravenously under the supervision of qualified healthcare professionals.

Q: What conditions is Campto indicated for?

A: Campto is used for the treatment of metastatic carcinoma of the colon or rectum as part of anticancer chemotherapy regimens, as determined by an oncologist.

Q: When is Campto contraindicated?

A: Campto should not be used in individuals with known hypersensitivity to Irinotecan or any of its components. It is important to consult a physician prior to initiation.

Q: Where should Campto - Irinotecan Injection be stored?

A: Store Campto vials between 2C to 8C, protected from light. Always check the expiration date before use and do not freeze the solution.

Q: What process ensures safe administration of Campto?

A: Administration should follow standard chemotherapy protocols, including proper dilution, use of sterile techniques, and monitoring for adverse reactions during the infusion.

Q: How does Campto benefit patients with colorectal cancer?

A: By interfering with cancer cell DNA replication, Campto slows down tumor growth, potentially improving survival and quality of life when included in a prescribed treatment regimen.

Get Latest Price